Scholar Rock Holding Corporation
General ticker "SRRK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.4B (TTM average)
Scholar Rock Holding Corporation follows the US Stock Market performance with the rate: 40.3%.
Estimated limits based on current volatility of 2.4%: low 39.00$, high 40.92$
Factors to consider:
- Total employees count: 289 (+47.4%) as of 2025
- Top business risk factors: Regulatory and compliance, Labor/talent shortage/retention, Insufficient capital, IP infringement, Market volatility
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [19.36$, 48.46$]
- 2026-12-31 to 2027-12-31 estimated range: [13.47$, 35.94$]
Financial Metrics affecting the SRRK estimates:
- Negative: with PPE of -13.1 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: 0.07 < Interest expense per share per price, % of 0.13
- Negative: -0.37 < Inventory ratio change, % of 0
- Negative: negative Industry operating income (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term SRRK quotes
Long-term SRRK plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $171.29MM | $252.05MM | $384.64MM |
| Operating Income | $-171.29MM | $-252.05MM | $-384.64MM |
| Non-Operating Income | $5.51MM | $5.76MM | $6.71MM |
| Interest Expense | $0.00MM | $0.00MM | $6.89MM |
| R&D Expense | $121.90MM | $184.55MM | $208.44MM |
| Income(Loss) | $-165.79MM | $-246.29MM | $-377.94MM |
| Net Income(Loss)* | $-165.79MM | $-246.29MM | $-377.94MM |
| Stockholders Equity | $225.22MM | $368.63MM | $245.49MM |
| Assets | $311.04MM | $474.92MM | $404.27MM |
| Operating Cash Flow | $-145.23MM | $-200.95MM | $-300.04MM |
| Capital expenditure | $0.07MM | $0.10MM | $0.60MM |
| Investing Cash Flow | $41.14MM | $-76.06MM | $218.69MM |
| Financing Cash Flow | $102.57MM | $353.03MM | $228.40MM |
| Earnings Per Share** | $-2.18 | $-2.47 | $-3.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.